Full Text View
Tabular View
Study Results
Related Studies
Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
This study has been completed.
Study NCT00334893   Information provided by National Cancer Institute (NCI)

First Received on June 7, 2006.   Last Updated on April 29, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial